Literature DB >> 17349785

Cancer incidence in AIDS patients in Catalonia, Spain.

Jaume Galceran1, Rafael Marcos-Gragera, Maria Soler, Amparo Romaguera, Alberto Ameijide, Angel Izquierdo, Joan Borràs, Sílvia de Sanjosé, Jordi Casabona.   

Abstract

HIV infected people and AIDS patients develop cancer more frequently than the general population. The objective of this study was to evaluate the risk of developing cancer among 15 to 69 year old AIDS patients from two geographic areas: Tarragona and Girona provinces, in north-eastern Spain. We have studied invasive and in situ cancers (for all sites) among 1659 AIDS patients from +/-5 years around the date of their AIDS diagnosis by matching the population-based Cancer Registries with the AIDS Registry covering these populations. The periods used in the linkage were 1981-1998 for Tarragona and 1994-1999 for Girona. Sex and age-standardised incidence ratios (SIRs) of observed-to-expected cancers were calculated by type of cancer as a measure of risk. For selected types of cancers, SIRs were also calculated for HIV exposure category. Compared with the general population, incidence of cancer among AIDS patients (invasive and in situ) increased 22.9 fold in men (n=142) and 21.0 fold in women (n=45). High statistically significant SIRs were found for Kaposi's sarcoma (KS) (male, 486.4; female, 1030.0), non-Hodgkin's lymphoma (NHL) (male, 126.1; female, 192.8) and invasive cervical cancer (41.8). High risks were also found for Hodgkin's lymphoma (31.1), liver cancer (29.4) and lung cancer (9.4) in men, and in situ cervical cancer (24.4) in women. For all non-AIDS defining malignant neoplasms as a group SIRs were 3.4 in men and 2.5 in women. Among men, homo/bisexuality was strongly related to risk of KS and NHL. The rates of cervical cancer, Hodgkin's lymphoma, liver cancer and lung cancer were among the highest ever reported linked to HIV infection. For the cervical cancer this could be attributable to the low incidence of this cancer in the general population and to the high prevalence of intravenous drug users among HIV women and probably due to poor preventive strategies in this population.

Entities:  

Mesh:

Year:  2007        PMID: 17349785     DOI: 10.1016/j.ejca.2007.01.028

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  15 in total

1.  Does HIV/AIDS have a biological impact on the risk of human papillomavirus-related cancers?

Authors:  Howard D Strickler
Journal:  J Natl Cancer Inst       Date:  2009-07-31       Impact factor: 13.506

2.  Cancer in HIV-infected persons from the Caribbean, Central and South America.

Authors:  Valeria I Fink; Bryan E Shepherd; Carina Cesar; Alejandro Krolewiecki; Firas Wehbe; Claudia P Cortés; Brenda Crabtree-Ramírez; Denis Padgett; Maryam Shafaee; Mauro Schechter; Eduardo Gotuzzo; Melanie Bacon; Catherine McGowan; Pedro Cahn; Daniel Masys
Journal:  J Acquir Immune Defic Syndr       Date:  2011-04-15       Impact factor: 3.731

Review 3.  HIV infection in the etiology of lung cancer: confounding, causality, and consequences.

Authors:  Gregory D Kirk; Christian A Merlo
Journal:  Proc Am Thorac Soc       Date:  2011-06

4.  HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer.

Authors:  Michael J Silverberg; Wendy Leyden; E Margaret Warton; Charles P Quesenberry; Eric A Engels; Maryam M Asgari
Journal:  J Natl Cancer Inst       Date:  2013-01-04       Impact factor: 13.506

5.  Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users.

Authors:  Meredith S Shiels; Stephen R Cole; Shruti H Mehta; Gregory D Kirk
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

6.  Are there any significant variations in the clinical or histological presentation of lymphoid pathologies over the course of time in Spain?

Authors:  Mariano Provencio; Pilar Sabín; José Gómez Codina; Antonio Rueda; Marta Llanos; Josep Gumá; Cristina Quero Blanco; Ana Blasco; Juan Ramón Delgado; Miguel Ángel Cruz; David Aguiar; Francisco Ramón García-Arroyo; Joaquín Herrero; Javier Lavernia; Natividad Martínez Banaclocha; Manuel Morales; José Fuster; Álvaro Sáez Cusi; Francisco Lobo; Delvys Rodríguez Abreu; Luis de la Cruz; Edelmira Antón; Alberto Rodríguez Jiménez; Alberto Arízcun; Xavi Pérez
Journal:  Clin Transl Oncol       Date:  2012-05       Impact factor: 3.405

7.  A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals.

Authors:  Meredith S Shiels; Stephen R Cole; Gregory D Kirk; Charles Poole
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12       Impact factor: 3.731

8.  Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study.

Authors:  Luigino Dal Maso; Silvia Franceschi; Mauro Lise; Priscilla Sassoli De' Bianchi; Jerry Polesel; Florio Ghinelli; Fabio Falcini; Alba C Finarelli
Journal:  BMC Cancer       Date:  2010-06-21       Impact factor: 4.430

Review 9.  Human immunodeficiency virus-associated lung malignancies.

Authors:  Allison A Lambert; Christian A Merlo; Gregory D Kirk
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

Review 10.  Evolving spectrum and incidence of non-AIDS-defining malignancies.

Authors:  Liron Pantanowitz; Bruce J Dezube
Journal:  Curr Opin HIV AIDS       Date:  2009-01       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.